Loading…

Steroid-induced avascular necrosis: A case report on a patient treated with steroid therapy for COVID-19

IntroductionCOVID-19 must get a combined approach that involves epidemiology, surveillance, accurate diagnosis, and prophylaxis. Corticosteroids use in the treatment of COVID-19, for a long time at high doses, can cause steroid-induced avascular necrosis. Case reportThe patient is a 22-year-old fema...

Full description

Saved in:
Bibliographic Details
Published in:Annals of medicine and surgery (2012) 2022, Vol.80, p.104226-104226
Main Authors: Maharjan, Gyabina, Yadav, Stuti, Yadav, Mandeep Kumar, Khati, Nirajan, Bhattarai, Himal Bikram, Joshi, Jaydev
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IntroductionCOVID-19 must get a combined approach that involves epidemiology, surveillance, accurate diagnosis, and prophylaxis. Corticosteroids use in the treatment of COVID-19, for a long time at high doses, can cause steroid-induced avascular necrosis. Case reportThe patient is a 22-year-old female. She came with a complaint of bilateral groin pain for 4 months. The pain was abrupt in onset, continuous, non-radiating, aggravated by walking and relieved with rest. We did an X-ray of the bilateral hips, blood tests, and MRI. With the investigations, we established the diagnosis of avascular necrosis of the femoral head. DiscussionIschemia of the femoral head is caused by any interruption in the blood supply of the acetabulum. It is induced by high-dose and long-term steroid usage. Glucocorticoids affect the metabolism of lipids which results in the formation of fat emboli and lipoprotein globules. This blocks peripheral vessels and leads to necrosis of the bone due to ischemia. ConclusionAvascular necrosis of the femoral head has been reported in patients treated with corticosteroids while being treated for COVID-19. So, physicians should keep it as a possible diagnosis and enhance their knowledge on this topic.
ISSN:2049-0801
2049-0801
DOI:10.1016/j.amsu.2022.104226